Dronedarone

BNF:: 2.3.2
Status:: Amber
Decision Date:: November 2017

Comments

See shared care guideline for the maintenance of sinus rhythm after successful cardioversion. (Decision date - November 2017).

Be aware of MHRA warnings

Amber Drug Classifications

2: Requiring short or medium term (e.g. 3-6 months) specialist monitoring of efficacy or until the patient is stable